产品详情
简单介绍：
Anti-ORMDL1 + ORMDL2 + ORMDL3抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-ORMDL1 + ORMDL2 + ORMDL3抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-ORMDL1 + ORMDL2 + ORMDL3
Cat. Number:
Anti-ORMDL1 + ORMDL2 + ORMDL3抗体KL-18035R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The ORMDL (ORM1-like) family of proteins consist of ORMDL1, ORMDL2 and ORMDL3; all of which are human homologs of the S. cerevisiae ORM1 protein. Localized to the membrane of the endoplasmic reticulum, ORMDLs
Anti-ORMDL1 + ORMDL2 + ORMDL3抗体are multi-pass membrane proteins that are implicated in ?secretase (BACE) function, as well as expression of Presenilin (PSI), a protein involved in Alzheimer抯 disease (AD). ORMDL1 (ORM1-like protein 1), also known as Adoplin-1, is a widely expressed 153 amino acid member of the ORMDL family. Expression of ORMDL1 is down-regulated in PSI mutations, suggesting a possible role as a therapeutic target for AD. ORMDL2 (ORM1-like protein 2), also known as Adoplin-2, and ORMDL3 (ORM1-like protein 3) are expressed in tissues such as heart, brain, lung, liver and kidney. ORMDL3 exists as two isoforms due to alternative splicing events and may be a determinant of susceptibility to childhood asthma
Specificity:
●
Rabbit Polyclonal IgG, affinity
Anti-ORMDL1 + ORMDL2 + ORMDL3抗体purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Cow, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ORMDL1 + ORMDL2 + ORMDL3.
●
Predicted Molecular Weight: 17kDa.
Storage:
Shipped at 4℃, Store at -20℃
Anti-ORMDL1 + ORMDL2 + ORMDL3抗体(Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-ORMDL1 + ORMDL2 + ORMDL3抗体
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-ORMDL1 + ORMDL2 + ORMDL3抗体
Optimal working dilutions must be determined by the end user.
